Services
What we do
Brizzey provides consulting services, training, tool design, selection and implementation, process modeling and project management. We pride ourselves on offering services that are good value, collaborative, supportive, focused, balanced and practical, in order to help organizations get to the next level.
TESTIMONIALS
I enjoy working with Brizzey because they truly understand the complexities of the business problems we face and help us identify the most effective solutions.
We have benefited greatly from the wealth of biopharma experience at Brizzey and couldn't be happier with the support and service provided to get our products to our patients.
Services
Combined Experience
We have 76+ years of combined experience across R&D, supply chain management, quality assurance, Process Optimization, and Organizational Change. We have worked together for 23+ years in R&D and supply chain roles and founded Brizzey in 2014.
Partners Experience
We have access to partners experienced in:
-
Pre-clinical Development
-
CMC Information Preparation
-
All Modalities of GMP Manufacturing
-
Leadership, Team Building, & Cultural Change
105+ Projects
We’ve delivered 105+ projects for 75 clients, including 29 sponsors, 4 CMOs, and 4 consulting groups.
Experience
Partners
Brizzey collaborates with a network of selected Partner Organizations to provide drug development services our clients need, but that fall outside our internal expertise.
Ultramikro, LLC is a consulting firm that guides the pharmaceutical and food industries on contamination control and global pharmacopeial compliance. Particulate matter in the pharmaceutical presentation may be foreign material or may form due to substances intrinsic to the formulation or package. Removing sub-visible (less than 100μm) and larger particles, or reducing their impact, depends on identifying them, which is facilitated by analysis using a variety of instruments and approaches. Microscopical applications are foremost in the Ultramikro approach.
Mark VanArendonk founded Vermeer Pharma, LLC in 2018. He has more than 30 years of pharmaceutical experience and specializes in CMC drug development. During his “big pharma” career, Mark held positions of increasing responsibility in Analytical R&D, Quality Assurance, and CMC at various companies, culminating in his role as Merck Vice President for Analytical Chemistry in Development and Supply, where he was responsible for late-stage development programs from IIB through registration, launch, and commercialization. As an independent consultant, Dr. VanArendonk supports small and medium-sized companies in early and late development.
Synergy Partners R&D Solutions is a network of scientists with deep experience across all aspects of pharmaceutical research and development, from target selection to clinical proof of concept and beyond. They have a track record of turning exciting discoveries into medicines by partnering with clients to design and implement the optimal development strategy for each molecule. Synergy can support you across all aspects of drug discovery and development, including biology, pharmacology, chemistry, drug safety, DMPK, clinical, and regulatory. Synergy will work with your team to design and oversee appropriate testing and integrate the knowledge gained into downstream plans to position your program for a seamless transition to development.
These established, long-term partnerships are designed to facilitate seamless execution of your project. Together, we will work with these trusted, highly skilled partners to drive your program to success.
The collaboration between Brizzey and Ultramikro ensures that the skills necessary to solve unexpected challenges during product development are available when needed.
We believe that the partnership between Brizzey and Vermeer Pharma brings together a dynamic combination of skills and experience that will facilitate our clients’ pathway to end-to-end development and increase the rate at which they can bring medicines to patients.
The collaboration between Brizzey and Synergy Partners brings broad expertise to your research and development programs and enables a seamless transition from research to development.
FarmCMC
John Skoug founded FarmCMC in 2019 to leverage his technical and leadership expertise to help small and medium-sized biopharmaceutical companies develop novel therapeutic assets and delivery systems through early and late stages.
John has more than 30 years of pharmaceutical industry experience and specializes in CMC product development across all stages of discovery and development. Prior to founding Farm CMC, he was Senior Director in AbbVie’s drug product R&D organization. There, he held several roles, where he led CMC technical strategy and execution for small molecule programs and combination product programs for biologics. John brings a unique breadth of CMC experience, including pharmaceutics support for discovery teams and drug and device delivery system technology assessment.
Together, Brizzey and FarmCMC offer a complementary set of skills and experience, which can help clients with a broad range of activities essential to the development of novel therapeutic assets and delivery systems.